01/27/2015 - 11:09am

Teva Pharmaceutical Industries announced that the Food and Drug Administration approved the company’s first generic Nexium delayed-release tablets in the United States.

01/27/2015 - 10:34am

The Food and Drug Administration on Monday announced approval for the first generic version of Nexium (esomeprazole magnesium delayed-release capsules), which are used to treat gastroesophageal reflux disease in adults and children ages 1 year and older.

01/26/2015 - 3:12pm

The Food and Drug Administration last week announced approval for Bexsero, a vaccine intended to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 years through 25 years of age.

 

01/26/2015 - 3:09pm

The Food and Drug Administration last week approved Natpara (parathyroid horomone), which is indicated to control low blood calcium levels in patients who have hypoparathyroidism.

 

01/23/2015 - 10:29am

CVS Health’s apprenticeship program garnered national attention during President Barack Obama’s State of the Union address on Tuesday as he called on more businesses to follow CVS Health’s lead and offer more educational benefits and paid apprenticeships.

01/22/2015 - 3:33pm

In support of pharmacy refill reminder programs and other healthcare communications by pharmacies, the National Association of Chain Drug Stores recently filed comments with the Federal Communications Commission requesting regulatory clarification regarding prior consent for calls to consumers’ cell phones for healthcare notifications.

01/22/2015 - 3:12pm

Four House representatives on Thursday reintroduced legislation designed to help prevent prescription drug abuse and diversion and ensure patient access to necessary medications.

01/21/2015 - 10:29pm

Not only was CVS Health president and CEO Larry Merlo a special guest of First Lady Michelle Obama for Tuesday night’s Presidential State of the Union address, but Merlo was also treated to a special shout out from the President.

 

01/21/2015 - 2:52pm

The Food and Drug Administration on Wednesday announced approval for Cosentyx (secukinumab), indicated for the treatment of adults with moderate to severe plaque psoriasis.